Previous
Next

āϏāϰ্āĻŦāĻļেāώ

Saturday, 11 July 2020

Corona said the cause of death

Corona said the cause of death

Many are commenting that the novel coronavirus is getting weaker than before. The number of deaths due to the new virus is also decreasing.

Explaining the reason, Indian cardiologist Kunal Sarkar said, "Looking at a few incidents, this issue cannot be emphasized." However, reading the history of the epidemic, it is known that after attacking people for a few months, the mortality rate decreases as our body somewhat compromises with the deadly power of germs.

However, he said that if the power of the epidemic virus is underestimated, the rules and regulations should be lifted.

Ashok Sengupta, a lung specialist in India, said it was not time to test the potential for the Kovid-19 virus. If Arera goes a week, there may be some speculation about the matter.

"The way we doctors were disoriented with the newly-identified virus called Kovid-19 in March-April is no longer the case," he said. The most serious aspect of the character of the virus is paralysis of the lungs, so we had no special weapon in our hands except to rely on a ventilator at the beginning of the infection.

Ashok Sengupta said that after learning about the blood clots in the respiratory tract of the victims of the virus attack, the problem of shortness of breath is being largely prevented with blood thinners.

Arindam Biswas, a doctor of internal medicine in India, said, "People who do not have other chronic diseases and are younger, may have fever, cough and a little body, arm and leg pain as symptoms of Kovid-19 infection." But that doesn't mean we should take Corona lightly. "

He said Arindam Babu felt that a lot of research and data analysis was needed before he could say for sure whether the virus was losing power.

The doctor warned that if the power of the virus is reduced now, there will be a tendency among the common people not to follow the hygiene rules. This can lead to out-of-control infections.

"People who have co-morbidity, such as high blood pressure, diabetes, chronic kidney disease or heart disease, and are over 60 years of age, are at risk of contracting the virus and are at risk of death," said Arindam.

Kunal Sarkar said that as many epidemics or epidemics have taken place in the last one thousand years, at the beginning of its terrible power, people also died. But gradually the virus becomes somewhat weaker, again the human body develops some resistance against the virus. Although it is not yet time to say anything definite about it. But maybe the Novelcrona virus is about to reach that stage.

"Thousands of people were being infected and dying before doctors knew what to do at the beginning of the Covid-19 epilepsy," he said. That matter has largely diminished. We have some weapons to suppress the virus. At the same time, the virus is changing their character. '

Arindam believes, ‘People’s awareness about Corona has increased a lot from before. As a result, people go to the doctor as soon as they see few symptoms. In addition, due to the low load of the virus due to the use of masks, the symptoms of some people are not getting worse than the five viral fevers.

However, doctors agree that it is inappropriate to go anywhere without a mask or to increase the crowd because the power of the virus has decreased. It will be easier to prevent infections other than the novel coronavirus if you follow the rules of health such as washing your hands with soap and wearing a mask according to the rules
Coroner gave the good news about the vaccine

Coroner gave the good news about the vaccine

Corona virus has spread in the form of a global epidemic. Scientists all over the world are doing everything possible for an effective vaccine to get rid of this deadly virus. Yet a vaccine does not match.

However, researchers are optimistic about some vaccines. One of them is the vaccine from Oxford University in Britain. It is the most advanced of the hundreds of vaccines.

This time Oxford University gave good news about this vaccine. They said that if all goes well, their vaccine will be available in October. And the price of this tick will be equal to the price of just one cup of coffee.

Not just Oxford, but Pfizer, a US pharmaceutical company, gave such good news two days ago. The US company has claimed that they will also bring the vaccine in October.

But ahead is the Oxford Corona vaccine. Their vaccine is now in the third phase of experimental application. The outcome or effectiveness of the third phase of the vaccine will be known by the end of August. Regulators will approve the vaccine for emergency use only if evidence of success is found in the test. That means high-risk patients will get the vaccine by October.

Kate Binham, chairman of the UK Vaccine Task Force, said Oxford was far ahead in vaccine development. Other vaccines may begin vaccinating Oxford long before their effectiveness is tested.

AstraZeneca, a British pharmaceutical company, is already building a supply chain to quickly deliver the Oxford vaccine internationally. Officials at the company say they have already received orders for 200 million doses of the vaccine. The cost of each dose of vaccine can be equal to the price of one cup of coffee.

AstraZeneca chief executive Pascal Sariot said their vaccine would be able to protect against Covid-19 for up to a year. If all goes well, the vaccine supply will start in October.

But ahead is the Oxford Corona vaccine. Their vaccine is now in the third phase of experimental application. The outcome or effectiveness of the third phase of the vaccine will be known by the end of August. Regulators will approve the vaccine for emergency use only if evidence of success is found in the test. That means high-risk patients will get the vaccine by October.

Kate Binham, chairman of the UK Vaccine Task Force, said Oxford was far ahead in vaccine development. Other vaccines may begin vaccinating Oxford long before their effectiveness is tested.

AstraZeneca, a British pharmaceutical company, is already building a supply chain to quickly deliver the Oxford vaccine internationally. Officials at the company say they have already received orders for 200 million doses of the vaccine. The cost of each dose of vaccine can be equal to the price of one cup of coffee.

AstraZeneca chief executive Pascal Sariot said their vaccine would be able to protect against Covid-19 for up to a year. If all goes well, the vaccine supply will start in October.

No more worries about the corona virus

No more worries about the corona virus

The competition for the vaccine against coronavirus is now in full swing. Discussions have also started on which company will bring the vaccine first. However, experts say that in order to decide how and when to bring the vaccine, various factors such as the safe side and effectiveness of the vaccine should be taken into consideration.
The University of Oxford in England is well ahead in the race to develop a potential vaccine. Top scientists at the World Health Organization have also cited the Oxford vaccine as a pioneer. The price will be affordable. The results of the third phase of the Oxford-made vaccine will be known by the end of August, according to a report in the British magazine The Economist. Whether the vaccine will protect against the 12 million people infected with the coronavirus worldwide depends on the results of the test.
The Economist says that once the test is successful, regulators will approve the vaccine for emergency use. In other words, those who are high risk patients will get the vaccine by October.
According to Australia's News.com.au, the British pharmaceutical company AstraZeneca is building a supply chain to supply the Oxford vaccine quickly and widely internationally. Officials at the company say the vaccine will need multiple tests to get full approval. Full approval could be obtained early next year.
British Prime Minister Boris Johnson described the vaccine competition as the most important partnership effort of our lives. Researchers at Oxford, led by Professor Sarah Gilbert, developed a vaccine based on a drug that had previously been effective in treating similar viruses. They have quickly begun large-scale human testing. Kate Binham, chairman of the UK Vaccine Task Force, said Oxford was far ahead in vaccine development. Other vaccines may begin vaccinating Oxford long before their effectiveness is tested.
AstraZeneca says they have already received orders for 200 million doses of the vaccine. The cost of each dose of vaccine can be equal to the price of one cup of coffee. AstraZeneca chief executive Pascal Sariot said their vaccine would be able to protect against Covid-19 for up to a year. If all goes well, the results will be known in August or September. Vaccine production continues as well as waiting for the vaccine to bear fruit. If all goes well, the vaccine supply can start in October.

Wednesday, 24 June 2020

āĻŽāĻ¨ā§āĻ¤ā§āϰāĻŋāϏāĻ­āĻž āĻĒā§āϰāϧāĻžāύāĻŽāĻ¨ā§āĻ¤ā§āϰ⧀āϕ⧇ āχāωāĻāύāĻĒāĻŋāĻāϏāĻ āĻĒ⧁āϰāĻ¸ā§āĻ•āĻžāϰ āĻœā§‡āϤāĻžāϰ āϜāĻ¨ā§āϝ āĻ…āĻ­āĻŋāύāĻ¨ā§āĻĻāύ āϜāĻžāύāĻŋā§Ÿā§‡āϛ⧇āύ āĻŽāĻ¨ā§āĻ¤ā§āϰāĻŋāĻĒāϰāĻŋāώāĻĻ

āĻŽāύ্āϤ্āϰিāϏāĻ­া āĻĒ্āϰāϧাāύāĻŽāύ্āϤ্āϰীāĻ•ে āχāωāĻāύāĻĒিāĻāϏāĻ āĻĒুāϰāϏ্āĻ•াāϰ āϜেāϤাāϰ āϜāύ্āϝ āĻ…āĻ­িāύāύ্āĻĻāύ āϜাāύি⧟েāĻ›েāύ āĻŽāύ্āϤ্āϰিāĻĒāϰিāώāĻĻ

āĻŽāύ্āϤ্āϰিāϏāĻ­া āĻĒ্āϰāϧাāύāĻŽāύ্āϤ্āϰীāĻ•ে āχāωāĻāύāĻĒিāĻāϏāĻ āĻĒুāϰāϏ্āĻ•াāϰ āϜেāϤাāϰ āϜāύ্āϝ āĻ…āĻ­িāύāύ্āĻĻāύ āϜাāύি⧟েāĻ›েāύ āĻŽāύ্āϤ্āϰিāĻĒāϰিāώāĻĻ


   āĻŽāύ্āϤ্āϰিāĻĒāϰিāώāĻĻ āĻĒ্āϰāϧাāύāĻŽāύ্āϤ্āϰী āĻļেāĻ– āĻšাāϏিāύাāĻ•ে āĻ…āĻ­িāύāύ্āĻĻāύ āϜাāύিāϝ়ে āĻāĻ•āϟি āĻĒ্āϰāϏ্āϤাāĻŦ āĻ—ৃāĻšীāϤ āĻšāϝ়েāĻ›ে āϝেāĻšেāϤু āĻŦাংāϞাāĻĻেāĻļ "āωāύ্āύāϝ়āύāĻļীāϞ āϏ্āĻŦāϚ্āĻ› āĻ“ āϜāĻŦাāĻŦāĻĻিāĻšি āĻĒ্āϰāϤিāώ্āĻ াāύāϏāĻŽূāĻš" āĻŦিāĻ­াāĻ—ে āĻŽāϰ্āϝাāĻĻাāĻĒূāϰ্āĻŖ āϜাāϤিāϏংāϘ āĻĒাāĻŦāϞিāĻ• āϏাāϰ্āĻ­িāϏ āĻ…্āϝাāĻ“āϝ়াāϰ্āĻĄ ⧍ā§Ļ⧍ā§Ļ (āχāωāĻāύāĻĒিāĻāϏāĻ ⧍ā§Ļ⧍ā§Ļ) āĻ…āϰ্āϜāύ āĻ•āϰেāĻ›ে।

 āĻŦুāϧāĻŦাāϰ āĻāĻ• āĻš্āϝাāύ্āĻĄāφāωāϟে āϜাāύাāύো āĻšāϝ়েāĻ›ে, ā§Ž āϜুāύ āĻŽāύ্āϤ্āϰিāĻĒāϰিāώāĻĻেāϰ āĻŦৈāĻ āĻ•ে āĻāχ āϏāĻŽ্āĻŽাāύāύা āĻĒ্āϰāϏ্āϤাāĻŦ āĻ—ৃāĻšীāϤ āĻšāϝ়েāĻ›িāϞ, āĻāĻŦং āĻŽāύ্āϤ্āϰিāĻĒāϰিāώāĻĻ āĻŦিāĻ­াāĻ— ā§§ā§Ģ āχ āϜুāύ āĻ āϏংāĻ•্āϰাāύ্āϤ āĻāĻ•āϟি āĻ—েāϜেāϟ āĻĒ্āϰāϜ্āĻžাāĻĒāύ āϜাāϰি āĻ•āϰেāĻ›ে, āĻŦুāϧāĻŦাāϰ āĻāĻ• āĻš্āϝাāύ্āĻĄāφāωāϟ āϜাāύাāϝ়।

 āĻ­ূāĻŽি āĻŽāύ্āϤ্āϰāĻ•েāϰ āχ-āĻŽিāωāϟেāĻļāύ āĻĒ্āϰোāĻ—্āϰাāĻŽ āϏāĻĢāϞāĻ­াāĻŦে āĻŦাāϏ্āϤāĻŦাāϝ়āύেāϰ āϜāύ্āϝ āĻŦাংāϞাāĻĻেāĻļ āχāωāĻāύāĻĒিāĻāϏāĻ ⧍ā§Ļ⧍ā§Ļ āϜিāϤেāĻ›ে।

 ā§¨ā§Ļ⧍ā§Ļ āϏাāϞেāϰ ā§§ āϜুāύ, āĻ…āϰ্āĻĨāύৈāϤিāĻ• āĻ“ āϏাāĻŽাāϜিāĻ• āĻŦিāώāϝ়āĻ• āĻŦিāώāϝ়āĻ• āωāĻĒ-āϏেāĻ•্āϰেāϟাāϰি-āϜেāύাāϰেāϞ āϞিāω āĻেāύāĻŽিāύ āϜাāϤিāϏংāϘেāϰ āϰাāώ্āϟ্āϰāĻĻূāϤ āϰাāĻŦাāĻŦ āĻĢাāϤিāĻŽাāĻ•ে āĻŦাংāϞাāĻĻেāĻļ āϏ্āĻĨাāϝ়ী āĻĒ্āϰāϤিāύিāϧিāĻ•ে āϜাāϤিāϏংāϘেāϰ āĻĒুāϰāώ্āĻ•াāϰ āϜāϝ়েāϰ āĻŦিāώāϝ়ে āĻ…āĻŦāĻšিāϤ āĻ•āϰেāĻ›িāϞেāύ।

 āϜাāϤিāϏংāϘেāϰ āφāύ্āĻĄাāϰ āϏেāĻ•্āϰেāϟাāϰি āϜেāύাāϰেāϞ āĻŦāϞেāĻ›েāύ, āχ-āĻŽিāωāϟেāĻļāύ āĻĒ্āϰোāĻ—্āϰাāĻŽেāϰ āĻŦাāϏ্āϤāĻŦাāϝ়āύ āĻŦাংāϞাāĻĻেāĻļেāϰ āϜāύ্āϝ āĻāĻ•āϟি āωāϞ্āϞেāĻ–āϝোāĻ—্āϝ āĻ…āϰ্āϜāύ āĻāĻŦং āĻāϟি āĻĻেāĻļেāϰ āϜāύ āĻĒ্āϰāĻļাāϏāύ āĻĒ্āϰāĻļাāϏāύেāϰ āωāύ্āύāϝ়āύে āĻ—ুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻ­ূāĻŽিāĻ•া āĻĒাāϞāύ āĻ•āϰāĻŦে।

 āĻŦাংāϞাāĻĻেāĻļ āĻĒ্āϰāĻĨāĻŽāĻŦাāϰেāϰ āĻŽāϤো āĻŽāϰ্āϝাāĻĻাāĻĒূāϰ্āĻŖ āχāωāĻāύ āĻĒুāϰāώ্āĻ•াāϰ āĻĒেāϝ়েāĻ›ে।

 āϰেāϜুāϞেāĻļāύ āĻ…āύুāϏাāϰে, āĻŽāύ্āϤ্āϰিāĻĒāϰিāώāĻĻ āĻŦিāĻļ্āĻŦাāϏ āĻ•āϰে āϝে āĻĒ্āϰāϧাāύāĻŽāύ্āϤ্āϰী āĻļেāĻ– āĻšাāϏিāύাāϰ āĻ—āϤিāĻļীāϞ āύেāϤৃāϤ্āĻŦ, āĻĒ্āϰāϜ্āĻžা, āĻĻূāϰāĻĻāϰ্āĻļিāϤা āĻāĻŦং āĻ•াāϰ্āϝāĻ•āϰ āϏিāĻĻ্āϧাāύ্āϤāĻ—ুāϞি āĻĻেāĻļে āĻ…āĻ­ূāϤāĻĒূāϰ্āĻŦ āϏাāĻĢāϞ্āϝ āĻ…āϰ্āϜāύে āϏāĻšাāϝ়āϤা āĻ•āϰেāĻ›ে।

 "āĻĄিāϜিāϟাāϞ āĻŦাংāϞাāĻĻেāĻļ" āĻ—āĻĄ়াāϰ āĻĻিāĻ•ে āϤাঁāϰ āĻĻূāϰāĻĻāϰ্āĻļী āωāĻĻ্āϝোāĻ—েāϰ āĻ•াāϰāĻŖে āĻāχ āϏāĻŽ্āĻŽাāύāϜāύāĻ• āĻĒুāϰāώ্āĻ•াāϰ āĻ…āϰ্āϜāύ āϏāĻŽ্āĻ­āĻŦ āĻšāϝ়েāĻ›িāϞ।

 āĻĒ্āϰāϧাāύāĻŽāύ্āϤ্āϰী āĻļেāĻ– āĻšাāϏিāύাāϰ āĻ…āĻ•্āϞাāύ্āϤ āĻĒāϰিāĻļ্āϰāĻŽ āĻ“ āĻĒ্āϰāϤ্āϝāĻ•্āώ āϤāϤ্āϤ্āĻŦাāĻŦāϧাāύে āĻ—āϤ āĻĻāĻļ āĻŦāĻ›āϰে āĻĻেāĻļেāϰ āĻ­ূāĻŽি āĻŦ্āϝāĻŦāϏ্āĻĨাāĻĒāύাāϝ় āφāĻŽূāϞ āĻĒāϰিāĻŦāϰ্āϤāύ āφāύা āĻšāϝ়েāĻ›ে।

 āχ-āĻŽিāωāϟেāĻļāύāϟি āĻŦāϰ্āϤāĻŽাāύ āϏāϰāĻ•াāϰেāϰ āĻ­িāĻļāύ ⧍ā§Ļ⧍ā§Ļ āĻ…āϰ্āϜāύে āĻāĻŦং āĻ­ূāĻŽি āϏেāĻŦাāϰ āĻ•্āώেāϤ্āϰে āϏ্āĻŦāϚ্āĻ›āϤা āĻ“ āϜāĻŦাāĻŦāĻĻিāĻšিāϤা āύিāĻļ্āϚিāϤ āĻ•āϰে āĻāĻ•āϟি āĻĄিāϜিāϟাāϞ āĻŦাংāϞাāĻĻেāĻļ āĻ—āĻ āύে āĻ—ুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻ­ূāĻŽিāĻ•া āĻĒাāϞāύ āĻ•āϰāĻŦে।

 āϤিāύ āĻĒাāϰ্āĻŦāϤ্āϝ āϜেāϞা āĻŦাāĻĻে āϏাāϰা āĻĻেāĻļে āχ-āĻŽিāωāϟেāĻļāύ āĻĒ্āϰāϝ়োāĻ— āĻ•āϰা āĻšāϚ্āĻ›ে।  āφāχāϏিāϟি āĻŦিāĻ­াāĻ—েāϰ āĻ ⧍ āφāχ āĻĒ্āϰāĻ•āϞ্āĻĒ āĻāχ āϞāĻ•্āώ্āϝে āĻĒ্āϰāϝুāĻ•্āϤিāĻ—āϤ āϏāĻšাāϝ়āϤা āĻĒ্āϰāĻĻাāύ āĻ•āϰে।

 āĻ­ূāĻŽি āϏংāϏ্āĻ•াāϰ āĻŦোāϰ্āĻĄেāϰ āĻĒāϰিāϚাāϞāύাāϝ় āϏāĻšāĻ•াāϰী āĻ•āĻŽিāĻļāύাāϰ (āĻ­ূāĻŽি) āĻāϰ āĻŽাāϧ্āϝāĻŽে āĻāϟি āĻŦাāϏ্āϤāĻŦাāϝ়āύ āĻ•āϰা āĻšāϚ্āĻ›ে।

Monday, 22 June 2020

Coronavirus: 'Life will live' in bed

Coronavirus: 'Life will live' in bed

A patient infected with Novel Coronavirus or Cavid-19 with severe respiratory distress was admitted to a hospital in New York, USA last Friday. The 40-year-old was in critical condition. Life support was in full swing. But with so many patients coming in, the pressure on the ICU continues to grow. Dr. Mangala Narasimhan then laid the patient on his back. This trick works like magic. After a while, the person began to breathe naturally. He no longer needed to be taken to the ICU.

According to a report by CNN Online, citing doctors treating people infected with coronavirus, if a person suffering from Covid-19 suffers from shortness of breath, he can be laid on his back to increase the supply of oxygen naturally. This method is called ‘prone positioning’.

Dr. Narasimhan said that this process works 100%. This is a very easy way. We see that the patient is improving tremendously.

Massachusetts General Hospital ICU Director. “You want to do the same thing over and over again when you see it working this way,” said Katherine Hibbert. And when a severe patient suffering from Covid-19 suffers from shortness of breath, lying on his back, it acts as a tonic.

Many patients with coronavirus suffer from severe shortness of breath. With this, if the person has pneumonia or any other complex disease, it becomes difficult to save him.

Seven years ago, a group of French doctors published a study in the New England Journal of Medicine. They showed that patients with shortness of breath who were placed on a ventilator had their chances of death greatly reduced by lying on their backs.

Doctors in the United States are already treating with this method. This method is now being used more in the country during the coronavirus epidemic.A New York hospital found that a coronavirus patient's oxygen supply increased from 85 percent to 96 percent after he was put to bed.

Patients who are on a ventilator are usually bedridden for 18 hours a day. Experts believe that it is easier for the patient to get oxygen if he is lying on his back. But when you lie down on your back, the supply of oxygen is interrupted
Scientists have expressed frustration with corona patients' antibodies

Scientists have expressed frustration with corona patients' antibodies

No successful vaccine for the deadly coronavirus (Covid-19) has yet been discovered. So the antibodies in the body of the patients are now the hope of survival. However, new research says that the level of antibodies in the body of patients who recover from Kovid-19 tends to decrease rapidly. Antibodies decrease within two to three months of being infected.
Chinese scientists have obtained such information by conducting research on the body of 19 patients with and without symptoms. This raises questions about the stability of the body's immune system against the novel coronavirus. The research article was published in the journal Nature Medicine on June 18.
Earlier, researchers said that those who have corona antibodies in their body have no problem moving outside. At present, efforts are being made to treat other Covid-19 patients with plasma antibodies in humans who have recovered from Covid-19. At this very moment, the researchers gave such information about the antibodies of Kovid-19 patients.
A study of blood antibodies in a total of 74 corona patients, 36 with symptoms and 36 with no symptoms, found that patients who had covid were identified in the presence of IgG antibodies (a type of antibody that is made after infection)In 90 percent of the patients, the level of antibodies in the body has dropped drastically in two-three monthsAntibodies have dropped by half in 80 percent of patients. Of those who had corona symptoms, 11.6 percent had antibodies, and of those who did not have symptoms, 6.3 percent had antibodies.
The study was conducted by Chongqing Medical University, a branch of China's Center for Disease Control and Prevention.
However, Jin Dong-yan, a professor in the Department of Virology at the University of Hong Kong (did not take part in the study), did not give up on the study. He said the study did not rule out lower levels of IgG antibodies, but did rule out other parts of the body's immune system.
He says that when someone first becomes infected, some cells become active in adapting to the virus, and these cells can develop an effective immune system even if they become infected in the second stage.
However, scientists are continuing to study whether this is also the case with coronavirus.
This study does not mean that the sky is falling over the head, the professor said. This is because research has been done on a very small number of patients
āĻŦā§āϰāĻžāϜāĻŋāϞ ā§Ģā§Ļ,ā§Ļā§Ļā§Ļ āĻšāĻžāϜāĻžāϰ āĻŽā§ƒāĻ¤ā§āϝ⧁āϰ āĻŽāĻžāϰāĻžāĻ¤ā§āĻŽāĻ• āĻŽāĻžāχāϞāĻĢāϞāĻ•āϕ⧇ āφāϘāĻžāϤ āĻ•āϰ⧇āϛ⧇

āĻŦ্āϰাāϜিāϞ ā§Ģā§Ļ,ā§Ļā§Ļā§Ļ āĻšাāϜাāϰ āĻŽৃāϤ্āϝুāϰ āĻŽাāϰাāϤ্āĻŽāĻ• āĻŽাāχāϞāĻĢāϞāĻ•āĻ•ে āφāϘাāϤ āĻ•āϰেāĻ›ে

āĻŦ্āϰাāϜিāϞ ā§Ģā§Ļ,ā§Ļā§Ļā§Ļ āĻšাāϜাāϰ āĻŽৃāϤ্āϝুāϰ āĻŽাāϰাāϤ্āĻŽāĻ• āĻŽাāχāϞāĻĢāϞāĻ•āĻ•ে āφāϘাāϤ āĻ•āϰেāĻ›ে


      āĻŦ্āϰাāϜিāϞ - āϰāĻŦিāĻŦাāϰ āĻŦ্āϰাāϜিāϞেāϰ āĻ•āϰোāύাāĻ­াāχāϰাāϏ āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āĻŽৃāϤ্āϝুāϰ āĻĒāϰিāĻŽাāĻŖ ā§Ģā§Ļ,ā§Ļā§Ļā§Ļ-āĻ›াāĻĄ়িāϝ়ে āĻ—েāĻ›ে, āĻĻেāĻļāϟিāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āĻ•āϰ্āϤৃāĻĒāĻ•্āώেāϰ āĻŦāϰাāϤ āĻĻিāϝ়ে āύিāωāϜ āϰিāĻĒোāϰ্āϟে āĻŦāϞা āĻšāϝ়েāĻ›ে,

āϏ্āĻŦাāϏ্āĻĨ্āϝ āĻŽāύ্āϤ্āϰāĻ•েāϰ āϤāĻĨ্āϝ āĻ…āύুāϝাāϝ়ী, āφāĻ—েāϰ āĻĻিāύ ā§Ŧā§Ēā§§āϜāύ āĻāύি⧟ āĻŽৃāϤ্āϝুāϰ āϏংāĻ–্āϝা āĻŦেāĻĄ়ে āĻĻাঁāĻĄ়িāϝ়েāĻ›ে ā§Ģā§Ļ,ā§Ŧā§§ā§­ āϜāύে।

āĻāϟি āĻ•্āϰāĻŽāĻŦāϰ্āϧāĻŽাāύ āϰাāϜāύৈāϤিāĻ• āωāϤ্āϤেāϜāύাāϰ āĻŽāϧ্āϝে āĻāϏেāĻ›িāϞ āĻāĻŦং āĻĻেāĻļāϟি ⧍ āĻŽিāϞিāϝ়āύেāϰāĻ“ āĻŦেāĻļি āĻ•āϰোāύāĻ­াāχāϰাāϏ āϏংāĻ•্āϰāĻŽāĻŖেāϰ āĻŦিāώāϝ়āϟি āύিāĻļ্āϚিāϤ āĻ•āϰাāϰ āĻ িāĻ• āĻ•āϝ়েāĻ•āĻĻিāύ āĻĒāϰে।

āĻĒāϰীāĻ•্āώাāĻ—ুāϞি āĻ•āĻŽ āĻĒāϰিāϚাāϞিāϤ āĻšāĻ“āϝ়াāϰ āĻ•াāϰāĻŖে āĻŦিāĻļেāώāϜ্āĻžāĻĻেāϰ āĻŽāϤে āφāĻ•্āϰাāύ্āϤেāϰ āϏংāĻ–্āϝা āϏāĻŽ্āĻ­āĻŦāϤ āĻ…āύেāĻ• āĻŦেāĻļি।

āϜāύ āĻšāĻĒāĻ•িāύ্āϏ āĻŦিāĻļ্āĻŦāĻŦিāĻĻ্āϝাāϞāϝ়েāϰ āĻāĻ• āϏāĻŽীāĻ•্āώাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে, āĻŦিāĻļ্āĻŦāĻŦ্āϝাāĻĒী, āĻļুāϧুāĻŽাāϤ্āϰ āĻŽাāϰ্āĻ•িāύ āϝুāĻ•্āϤāϰাāώ্āϟ্āϰāχ ā§§,ā§§ā§Ļ,ā§Ļā§Ļā§Ļ āĻāϰāĻ“ āĻŦেāĻļি āϏংāĻ–্āϝাāϝ় āĻāĻŦং āφāϰāĻ“ āϏংāĻ•্āϰāĻŽāĻŖে āϰেāĻ•āϰ্āĻĄ āĻ•āϰেāĻ›ে।

āϞāĻ•āĻĄাāωāύেāϰ āĻŦিāϰোāϧিāϤা āĻāĻŦং āĻ…āϰ্āĻĨāύীāϤিāϤে āĻĻৃāώ্āϟি āύিāĻŦāĻĻ্āϧ āĻ•āϰাāϰ āĻŦ্āϰাāϜিāϞেāϰ āϏুāĻĻূāϰ-āĻĄাāύ āϰাāώ্āϟ্āϰāĻĒāϤি āϜাāϝ়েāϰ āĻŦāϞāϏোāύাāϰোāϰ āϏিāĻĻ্āϧাāύ্āϤāϟি āĻŦ্āϝাāĻĒāĻ• āĻŦিāĻ­াāϜāύāĻ•াāϰী āĻšāϝ়েāĻ›ে।

āĻĻুāχ āϏ্āĻŦাāϏ্āĻĨ্āϝāĻŽāύ্āϤ্āϰী - āωāĻ­āϝ় āϚিāĻ•িā§ŽāϏāĻ• - āĻŽৃāϤ্āϝু āĻ“ āϏংāĻ•্āϰāĻŽāĻŖ āĻŦেāĻĄ়ে āϝাāĻ“āϝ়াāϝ় āϤাāĻĻেāϰ āĻĒāĻĻ āϤ্āϝাāĻ— āĻ•āϰেāĻ›েāύ। āĻĒ্āϰāĻĨāĻŽāϟি āĻŦāϞāϏোāύাāϰো āĻŦāϰāĻ–াāϏ্āϤ āĻ•āϰেāĻ›িāϞেāύ, āĻĻ্āĻŦিāϤীāϝ় āϰাāώ্āϟ্āϰāĻĒāϤিāϰ āϏাāĻĨে āĻāĻ•āĻŽāϤ āύা āĻšāĻ“āϝ়াāϰ āĻĒāϰে āĻĒāĻĻāϤ্āϝাāĻ— āĻ•āϰেāĻ›েāύ।

āĻŦ্āϰাāϜিāϞ āϏাāĻŽ্āĻĒ্āϰāϤিāĻ• āĻĻিāύে āĻāĻ• āĻšাāϜাāϰেāϰ āĻŽāϤো āĻŽৃāϤ্āϝুāϰ āϰেāĻ•āϰ্āĻĄ āĻ•āϰāĻ›ে, āϝāĻĻিāĻ“ āϏাāĻĒ্āϤাāĻšিāĻ• āĻ›ুāϟিāϰ āĻĒāϰিāϏংāĻ–্āϝাāύ āĻ•āĻŽ āĻĨাāĻ•ে। āĻ…āύেāĻ• āĻŦিāĻļেāώāϜ্āĻž āĻŦিāĻļ্āĻŦাāϏ āĻ•āϰেāύ āϝে āϜাāϤীāϝ়āĻ­াāĻŦে āĻĒāϰীāĻ•্āώাāϰ āĻ…āĻ­াāĻŦ āϰāϝ়েāĻ›ে - āϤাāĻĻেāϰ āĻŽāϧ্āϝে āĻ•েāω āĻ•েāω āĻŦāϞেāύ āϝে āϏ্āϤāϰāϟি āĻĒ্āϰāϝ়োāϜāύেāϰ āϚেāϝ়ে ⧍ā§Ļ āĻ—ুāĻŖ āĻ•āĻŽ - āĻĒ্āϰāϏ্āϤাāĻŦিāϤ āϏাāĻŽāĻ—্āϰিāĻ• āĻĒāϰিāϏংāĻ–্āϝাāύāĻ—ুāϞি āϝāĻĨেāώ্āϟ āĻŦেāĻļি āĻšāϤে āĻĒাāϰে।  

Sunday, 21 June 2020

āφāϜ āϰāĻŦāĻŋāĻŦāĻžāϰ ⧍⧧ āĻļ⧇ āϜ⧁āύ, āĻŦāĻŋāĻļā§āĻŦ āĻĒāĻŋāϤāĻž āĻĻāĻŋāĻŦāϏ

āφāϜ āϰāĻŦিāĻŦাāϰ ⧍⧧ āĻļে āϜুāύ, āĻŦিāĻļ্āĻŦ āĻĒিāϤা āĻĻিāĻŦāϏ

āφāϜ āϰāĻŦিāĻŦাāϰ ⧍⧧ āĻļে āϜুāύ, āĻŦিāĻļ্āĻŦ āĻĒিāϤা āĻĻিāĻŦāϏ


   āĻŦিāĻļ্āĻŦাāϏ āĻ“ āĻ›াāϝ়াāϰ āύাāĻŽ āĻĒিāϤা।  āĻŦাāĻŦা āĻŽাāύে āĻĒ্āϰāϚāύ্āĻĄ āϰোāĻĻেāϰ āύীāϚে āϏāύ্āϤাāύেāϰ āĻļীāϤāϞ āĻ›াāϝ়া।  āĻŦাāĻŦা āĻŽাāύে āĻŦিāĻļ্āĻŦাāϏ।  āφāĻŦাāϰ āĻĒিāϤা āϚিāϰāύ্āϤāύ, āĻĒিāϤা āϚিāϰāύ্āϤāύ।  āϤিāύি āĻĒāϰāĻŽ āύিāϰ্āĻ­āϰāϤাāϰ āĻĒ্āϰāϤীāĻ•।  āĻĒ্āϰāϤি āĻŦāĻ›āϰ āϜুāύেāϰ āϤৃāϤীāϝ় āϰāĻŦিāĻŦাāϰ āĻŦিāĻļ্āĻŦ āĻŦাāĻŦা āĻĻিāĻŦāϏ āĻĒাāϞিāϤ āĻšāϝ়।  āϏেāχ āĻšিāϏাāĻŦে, āĻāχ āĻŦāĻ›āϰেāϰ 21 āĻļে āϜুāύ āĻŦিāĻļ্āĻŦ āĻĒিāϤা āĻĻিāĻŦāϏ।  āĻŦিāĻļ্āĻŦ āĻŦাāĻŦা āĻĻিāĻŦāϏ āĻĒ্āϰāϤি āĻŦāĻ›āϰ āĻĒিāϤাāĻĻেāϰ āϜāύ্āϝ āĻāĻ•āϟি āĻŦিāĻļেāώ āĻĻিāύ āĻšিāϏাāĻŦে āĻĒাāϞāύ āĻ•āϰা āĻšāϝ়।

  āĻšাāĻĻীāϏে āĻŦāϰ্āĻŖিāϤ āĻšāϝ়েāĻ›ে āϝে, āϰাāϏূāϞুāϞ্āϞাāĻš āϏাāϞ্āϞাāϞ্āϞাāĻšু āφāϞাāχāĻšি āĻ“āϝ়াāϏাāϞ্āϞাāĻŽ āĻŦāϞেāĻ›েāύ, 'āφāϞ্āϞাāĻšāϰ āϏāύ্āϤুāώ্āϟি āĻĒিāϤাāϰ āϏāύ্āϤুāώ্āϟিāϰ āĻŽāϧ্āϝেāχ āĻĨাāĻ•ে āĻāĻŦং āφāϞ্āϞাāĻšāϰ āϏāύ্āϤুāώ্āϟি āĻĒিāϤাāϰ āĻ…āϏāύ্āϤুāώ্āϟিāϰ āĻŽāϧ্āϝেāχ āĻĨাāĻ•ে।' (āϤিāϰāĻŽিāϜি-ā§§ā§Žā§¯ā§¯)  )।

  āĻŦাāĻŦা āĻš'āϞ āϏāύ্āϤাāύেāϰ āĻŽাāĻĨাāϝ় āĻŦāϟāĻ—াāĻ›েāϰ āĻ›াāϝ়াāϰ āĻŽāϤো, āϝাāϰ āϏ্āύেāĻš āĻ•েāĻŦāϞ āĻ…āϟুāϟ āĻĒ্āϰāĻŦাāĻšে āĻĒ্āϰāĻŦাāĻšিāϤ।  āĻŦাāϚ্āϚাāϰ āĻ…āϞ্āĻĒ āĻŦāϝ়āϏী āĻŦাāĻŦাāϰ āĻšাāϤ āϝāĻ–āύ āĻŦাāĻŦাāϰ āĻšাāϤ āϧāϰে āĻšাঁāϟāĻ›ে āϤāĻ–āύ āϤা āϤাāĻĻেāϰ āĻāχ āĻ…āϟুāϟ āϏāĻŽ্āĻĒāϰ্āĻ•েāϰ āĻ•āĻĨা āĻ…āĻŦāĻšিāϤ āĻ•āϰে।

  āϏāύ্āϤাāύেāϰ āĻ­াāϞোāϰ āϜāύ্āϝ āĻĒিāϤাāĻ•ে āϜীāĻŦāύেāϰ āĻĒ্āϰাāϝ় āϏāĻŽāϏ্āϤ āĻ•িāĻ›ুāχ āϤ্āϝাāĻ— āĻ•āϰāϤে āĻšāϝ়।  āĻŦাāĻŦা āĻš'āϞ āφāĻĻāϰ āĻ“ āφāύুāĻ—āϤ্āϝেāϰ āϜাāϝ়āĻ—া।  āĻŦাāĻŦাāϰ āĻŽাāϧ্āϝāĻŽে āϏāύ্āϤাāύেāϰ āϜীāĻŦāύ āĻļুāϰু āĻšāϝ়।  āϏāύ্āϤাāύ āĻ•āĻ–āύāĻ“ āĻŦাāĻŦাāϰ debtāĻŖāĻ“ āĻŽাāĻĒāϤে āĻĒাāϰে āύা।  āϏেāχ āĻŦাāĻŦাāϰ āĻĒ্āϰāϤি āĻļ্āϰāĻĻ্āϧা āϜাāύাāϤে āϏাāϰা āĻŦিāĻļ্āĻŦāϜুāĻĄ়ে āĻĒাāϞিāϤ āĻšāϚ্āĻ›ে āĻĢাāĻĻাāϰ্āϏ āĻĄে।

  āĻĒ্āϰāĻ•ৃāϤāĻĒāĻ•্āώে, āĻāχ āĻĻিāύāϟি āĻĻেāĻ–াāϤে āωāĻĻāϝাāĻĒিāϤ āĻšāϝ় āϝে āĻŽাāϝ়েāĻĻেāϰ āĻĒাāĻļাāĻĒাāĻļি āĻĒিāϤাāϰাāĻ“ āϤাāĻĻেāϰ āϏāύ্āϤাāύেāϰ āϜāύ্āϝ āĻĻাāϝ়ী।  āĻāϟি āĻŦিāĻļ্āĻŦেāϰ āϏāĻŽāϏ্āϤ āĻĒিāϤাāĻ•ে āĻļ্āϰāĻĻ্āϧা āĻ“ āĻ­াāϞāĻŦাāϏা āĻĻেāĻ–াāύোāϰ āφāĻ•াāĻ™্āĻ•্āώা āĻĻিāϝ়ে āĻļুāϰু āĻšāϝ়।

  āĻŦিāĻŦিāϏিāϰ āĻāĻ•āϟি āĻĒ্āϰāϤিāĻŦেāĻĻāύে āĻŦāϞা āĻšāϝ়েāĻ›ে, āĻ•āϝ়েāĻ• āĻŦāĻ›āϰ āϧāϰে āĻŽাāĻĻাāϰ্āϏ āĻĄে āωāĻĻāϝাāĻĒিāϤ āĻšāϚ্āĻ›ে, āϤāĻŦে āĻĢাāĻĻাāϰ্āϏ āĻĄে āĻāϰ āϚেāϝ়ে āĻ…āύেāĻ• āύāϤুāύ।  āĻĻিāύāϟি āϏāĻŽ্āĻ­āĻŦāϤ āϝুāĻ•্āϤāϰাāώ্āϟ্āϰে āĻĒ্āϰāĻĨāĻŽ āϚাāϞু āĻšāϝ়েāĻ›িāϞ āĻāĻŦং āĻāϰ āϏূāϚāύা āϏāĻŽ্āĻĒāϰ্āĻ•ে āĻŦেāĻļ āĻ•āϝ়েāĻ•āϟি āĻ—āϞ্āĻĒ āϰāϝ়েāĻ›ে are

  āϏāϰ্āĻŦাāϧিāĻ• āϜāύāĻĒ্āϰিāϝ় āĻāĻŦং āϏāĻŽ্āĻ­āĻŦāϤ āϏ্āĻŦীāĻ•ৃāϤ āĻ—āϞ্āĻĒāϟি āĻš'āϞ āĻ“āϝ়াāĻļিংāϟāύেāϰ āϏোāύোāϰা āϞুāχāϏ āϏ্āĻŽাāϰ্āϟ āύাāĻŽে āĻāĻ• āĻŽāĻšিāϞা āĻāχ āĻĻিāύāϟি āωāĻĻāϝাāĻĒāύ āĻļুāϰু āĻ•āϰেāĻ›িāϞেāύ।  āϝāĻ–āύ āϤাāϰ āĻŽা āϤাāϰ āώāώ্āĻ  āϏāύ্āϤাāύেāϰ āϜāύ্āĻŽ āĻĻেāĻ“āϝ়াāϰ āϏāĻŽāϝ় āĻŽাāϰা āĻ—েāϞেāύ, āϤাāϰ āĻŦাāĻŦা āĻĒāϰিāĻŦাāϰāĻ•ে āĻŦāĻĄ় āĻ•āϰেāĻ›েāύ।

  āϏোāύোāϰা āϚাāϰ্āϚে 1909 āϏাāϞেāϰ āĻ­াāώāĻŖে āφāĻĒāύি āĻŽা āĻĻিāĻŦāϏ āϏāĻŽ্āĻĒāϰ্āĻ•ে āϜাāύāϤে āĻĒাāϰেāύ।  āϤāĻ–āύ āϤিāύি āĻ­াāĻŦāϞেāύ, āĻŦাāĻŦাāϰ āϜāύ্āϝāĻ“ āĻāĻŽāύ āĻāĻ•āϟি āĻĻিāύ āĻĨাāĻ•া āωāϚিāϤ।

  āĻŦেāĻļ āĻ•āϝ়েāĻ•āϟি āϏ্āĻĨাāύীāϝ় āĻĒুāϰোāĻšিāϤ āϤাāϰ āϧাāϰāĻŖা āĻ—্āϰāĻšāĻŖ āĻ•āϰেāĻ›িāϞেāύ।  āĻāϟি āφāύুāώ্āĻ াāύিāĻ• āύা āĻšāϞেāĻ“, ⧧⧝⧧ā§Ļ, ⧧⧝⧧ā§Ļ āϏাāϞে āĻĒ্āϰāĻĨāĻŽāĻŦাāϰেāϰ āĻŽāϤো āĻĢাāĻĻাāϰ্āϏ āĻĄে āĻĒাāϞāύ āĻ•āϰা āĻšāϝ়েāĻ›িāϞ āĻŦāϞে āĻŽāύে āĻ•āϰা āĻšāϝ়।

  1978 āϏাāϞে, āĻŽাāϰ্āĻ•িāύ āϰাāώ্āϟ্āϰāĻĒāϤি āϞিāύ্āĻĄāύ āĻŦি āϜāύāϏāύ āϏিāĻĻ্āϧাāύ্āϤ āύিāϝ়েāĻ›িāϞেāύ āϝে āĻĒ্āϰāϤিāĻŦāĻ›āϰ āϜুāύেāϰ āϤৃāϤীāϝ় āϰāĻŦিāĻŦাāϰ āĻĢাāĻĻাāϰ্āϏ āĻĄে āĻšিāϏাāĻŦে āωāĻĻāϝাāĻĒিāϤ āĻšāĻŦে।

  āĻ›āϝ় āĻŦāĻ›āϰ āĻĒāϰে āϰাāώ্āϟ্āϰāĻĒāϤি āϰিāϚাāϰ্āĻĄ āύিāĻ•āϏāύ āĻāϟি āĻ•াāϰ্āϝāĻ•āϰ āĻ•āϰেāĻ›িāϞেāύ।

Saturday, 20 June 2020

āφāĻŽāĻŋ 'āĻŦāĻŋāĻļ⧇āώ āϏāĻŽāϝāĻŧ' āĻŦā§āϝāϝāĻŧ āύāĻž āĻ•āϰāĻžāϝāĻŧ āϏāĻŋāύ⧇āĻŽāĻžāϟāĻŋ āĻŦāĻžāĻĻ āĻĻāĻŋāϝāĻŧ⧇āĻ›āĻŋāϞāĻžāĻŽ: āĻļā§āϰ⧀āϞ⧇āĻ–āĻž

āφāĻŽি 'āĻŦিāĻļেāώ āϏāĻŽāϝ়' āĻŦ্āϝāϝ় āύা āĻ•āϰাāϝ় āϏিāύেāĻŽাāϟি āĻŦাāĻĻ āĻĻিāϝ়েāĻ›িāϞাāĻŽ: āĻļ্āϰীāϞেāĻ–া

āφāĻŽি 'āĻŦিāĻļেāώ āϏāĻŽāϝ়' āĻŦ্āϝāϝ় āύা āĻ•āϰাāϝ় āϏিāύেāĻŽাāϟি āĻŦাāĻĻ āĻĻিāϝ়েāĻ›িāϞাāĻŽ: āĻļ্āϰীāϞেāĻ–া


   āĻŦāϞিāωāĻĄ āĻ…āĻ­িāύেāϤা āϏুāĻļাāύ্āϤ āϏিং āϰাāϜāĻĒুāϤেāϰ āφāϤ্āĻŽāĻšāϤ্āϝাāϰ āĻĒāϰে āϚāϞāϚ্āϚিāϤ্āϰ āϜāĻ—āϤেāϰ āϜāϘāύ্āϝ āϰাāϜāύীāϤি āĻ“ āĻĒāĻ•্āώāĻĒাāϤিāϤ্āĻŦ āϏāĻŦাāϰ āϏাāĻŽāύে āφāϏāĻ›ে। āϤিāύি āφāϰāĻ“ āĻŦāϞেāĻ›িāϞেāύ, āĻŦāϞিāωāĻĄেāϰ āĻ…āύেāĻ• āϤাāϰāĻ•া āĻšāϤাāĻļাāϝ় āĻ­ুāĻ—āĻ›েāύ।

āϏুāĻļাāύ্āϤāϰāϰ āφāϤ্āĻŽāĻšāϤ্āϝাāϰ āĻĒ্āϰāĻ­াāĻŦ āϟাāϞিāωāĻĄ āχāύ্āĻĄাāϏ্āϟ্āϰিāϤেāĻ“ āĻĒāĻĄ়েāĻ›িāϞ। āϟাāϞিāωāĻĄ āĻ…āĻ­িāύেāϤ্āϰী āĻļ্āϰীāϞেāĻ–া āĻŽিāϤ্āϰ āĻŦিāώāϝ়āϟি āύিāϝ়ে āĻŽুāĻ– āĻ–ুāϞāϞেāύ।

āĻ…āĻ­িāύেāϤ্āϰী āĻāĻ•āϟি āĻ­াāϰāϤীāϝ় āĻ—āĻŖāĻŽাāϧ্āϝāĻŽāĻ•ে āϜাāύিāϝ়েāĻ›েāύ āϝে āχāύ্āĻĄাāϏ্āϟ্āϰিāϤে āĻļিāĻŦিāϰ āϰāϝ়েāĻ›ে। āφāϰ āĻāĻ•āϜāύ āĻ…āĻ­িāύেāϤা āĻŽুāĻ­ি āĻĨেāĻ•ে āύাāϝ়āĻ• āĻŦা āϤাāϰ āĻĒ্āϰেāĻŽিāĻ•েāϰ āϏুāϰে āϏāϰে āϝাāϝ়। āĻāĻ—ুāϞি āϟাāϞিāωāĻĄে āĻĻীāϰ্āϘāĻĻিāύ āϧāϰে āϚāϞāĻ›ে। āφāϜ āφāĻŽāϰা āϏুāĻļাāύ্āϤেāϰ āφāϤ্āĻŽāĻšāϤ্āϝাāϰ āĻ•াāϰāĻŖে āĻļিāϞ্āĻĒেāϰ āϜāϘāύ্āϝ āϰাāϜāύীāϤি āύিāϝ়ে āϏোāϚ্āϚাāϰ।

āĻļ্āϰীāϞেāĻ–া āύিāϜেāχ āύিāϜেāϰ āĻ…āĻ­িāύāϝ় āϜীāĻŦāύে āĻĒāĻ•্āώāĻĒাāϤেāϰ āĻļিāĻ•াāϰ āĻšāϝ়েāĻ›েāύ। āĻ…āĻ­িāύেāϤ্āϰী āϜাāύিāϝ়েāĻ›েāύ, āĻ…āύ্āύāĻĻাāϟা āϏিāύেāĻŽাāϟি āϏুāĻĒাāϰ āĻšিāϟ। āĻĒāϰেāϰ āϏিāύেāĻŽাāϤে āϏ্āĻŦাāĻ•্āώāϰ āĻ•āϰাāϰ āĻ•āϝ়েāĻ• āĻĻিāύ āĻĒāϰে āφāĻŽি āϜাāύāϤে āĻĒেāϰেāĻ›িāϞাāĻŽ āϝে āφāĻŽি āĻŦাāĻĻ āĻĒāĻĄ়েāĻ›ি। āĻŽুāĻ­িāϟিāϰ āύাāϝ়āĻ•েāϰ āĻĒ্āϰেāĻŽে āϝাāĻ•ে āĻĒ্āϰেāĻŽ āĻ•āϰা āĻšāϝ়েāĻ›ে, āϏেāχ āĻĻাāĻŦিāϟিāχ āϤাঁāϰ āĻ•াāĻ›ে āĻāϞো।

āύিāϰ্āĻŽাāϤা-āĻĒāϰিāϚাāϞāĻ•েāϰ āϏাāĻĨে āϏāĻŽāϝ় āύা āĻ•াāϟাāύোāϰ āĻ•াāϰāĻŖে āĻ…āύেāĻ• āϏিāύেāĻŽা āĻĨেāĻ•ে āĻŦাāĻĻ āĻĒāĻĄ়েāĻ›েāύ āĻļ্āϰীāϞেāĻ–া। āĻ…āĻ­িāύেāϤ্āϰী āĻŦāϞেāĻ›িāϞেāύ, "āφāĻŽি āĻĒাāϰ্āϟিāĻļāύ āĻĒ্āϰāϝোāϜāĻ•-āĻĒāϰিāϚাāϞāĻ•েāϰ āϏাāĻĨে āύৈāĻļāĻ­োāϜে āϝাāχāύি āĻāĻŦং āĻŦিāĻļেāώ āϏāĻŽāϝ় āĻŦ্āϝāϝ় āĻ•āϰি āύি āĻŦāϞে āĻ…āύেāĻ• āϏিāύেāĻŽা āĻĨেāĻ•ে āĻŦাāĻĻ āĻĒāĻĄ়েāĻ›ি।" āĻāϟি āφāĻŽাāϰ āĻŽāύ āĻ–াāϰাāĻĒ āĻ•āϰেāĻ›ে āĻ•িāύ্āϤু āφāĻŽাāϰ āĻŽāύোāĻŦāϞ āĻ­াāĻ™েāύি।

Tuesday, 16 June 2020

āϰ⧇āĻĄ āĻœā§‹āύ⧇ āĻŦā§āϝāĻžāĻ‚āĻ•āϗ⧁āϞāĻŋ āĻŦāĻ¨ā§āϧ āĻĨāĻžāĻ•āĻŦ⧇

āϰেāĻĄ āϜোāύে āĻŦ্āϝাংāĻ•āĻ—ুāϞি āĻŦāύ্āϧ āĻĨাāĻ•āĻŦে

āϰেāĻĄ āϜোāύে āĻŦ্āϝাংāĻ•āĻ—ুāϞি āĻŦāύ্āϧ āĻĨাāĻ•āĻŦে


  āϤāĻŦে āϏংāĻļ্āϞিāώ্āϟ āĻ•āϰ্āϤৃāĻĒāĻ•্āώ āϝāĻĻি āĻāĻ—ুāϞি āωāύ্āĻŽুāĻ•্āϤ āĻ•āϰāϤে āϚাāύ āϤāĻŦে āĻļাāĻ–াāĻ—ুāϞি āϏীāĻŽিāϤ āφāĻ•াāϰে āĻĒāϰিāϚাāϞিāϤ āĻšāĻŦে āĻŦāϞে āĻ•েāύ্āĻĻ্āϰীāϝ় āĻŦ্āϝাংāĻ• āϜাāύিāϝ়েāĻ›ে

āĻŦাংāϞাāĻĻেāĻļ āĻŦ্āϝাংāĻ• (āĻŦিāĻŦি) āĻ•োāĻ­িāĻĄ -⧧⧝ āϏংāĻ•্āϰāĻŽāĻŖ āĻāĻŦং āĻŽৃāϤ্āϝুāϰ āĻ­িāϤ্āϤিāϤে āϚিāĻš্āύিāϤ āϰেāĻĄ āϜোāύ āĻāĻŦং āĻ…āύ্āϝাāύ্āϝ āĻুঁāĻ•িāĻĒূāϰ্āĻŖ āĻ…āĻž্āϚāϞে āĻļাāĻ–াāĻ—ুāϞিāϰ āϜāύ্āϝ āύāϤুāύ āĻŦ্āϝাংāĻ•িংāϝ়েāϰ āĻāĻ•āϟি āĻļāϰ্āϤ āϘোāώāĻŖা āĻ•āϰেāĻ›ে।

“āϰেāĻĄ āϜোāύে āĻŦ্āϝাংāĻ• āĻļাāĻ–া āĻŦāύ্āϧ āĻĨাāĻ•āĻŦে। āϤāĻŦে, āϏ্āĻŦাāϏ্āĻĨ্āϝ āĻŦিāĻ­াāĻ—, āϏিāϟি āĻ•āϰ্āĻĒোāϰেāĻļāύ āĻŦা āϜেāϞা āĻ•āϰ্āϤৃāĻĒāĻ•্āώ āϝāĻĻি āϰেāĻĄ āϜোāύে āĻļাāĻ–া āĻ–োāϞাāϰ āύিāϰ্āĻĻেāĻļ āĻĻেāϝ় āϤāĻŦে āϤাāϰা āϏীāĻŽিāϤ āφāĻ•াāϰে āĻ•াāϜ āĻ•āϰāĻŦে, āϏীāĻŽিāϤ āϏংāĻ–্āϝāĻ• āĻ•āϰ্āĻŽী āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰে āĻāĻŦং āϏāĻ•াāϞ āĻĻāĻļāϟা āĻĨেāĻ•ে āϰাāϤ āϏাāĻĄ়ে āĻŦাāϰāϟা āĻĒāϰ্āϝāύ্āϤ āĻ•্āϞাāϝ়েāύ্āϟ āĻ—্āϰāĻšāĻŖ āĻ•āϰāĻŦে, ”āĻāĻ•āϜāύ āĻŦāϞেāĻ›েāύ āϏোāĻŽāĻŦাāϰ āϜাāϰি āĻ•āϰা āĻŦিāĻŦি āĻŦিāϜ্āĻžāĻĒ্āϤি।

āϤāĻŦে āĻļাāĻ–াāĻ—ুāϞি āϏāϰāĻ•াāϰী āĻ•াāϜ āĻļেāώ āĻ•āϰাāϰ āϜāύ্āϝ āĻŦেāϞা āĻĻেāĻĄ়āϟা āĻĒāϰ্āϝāύ্āϤ āωāύ্āĻŽুāĻ•্āϤ āĻĨাāĻ•āĻŦে।

āĻŦিāϜ্āĻžāĻĒ্āϤি āĻ…āύুāϏাāϰে, āϝāĻĻি āĻ•োāύāĻ“ āĻŦ্āϝাংāĻ•েāϰ āĻĒ্āϰāϧাāύ āĻ•াāϰ্āϝাāϞāϝ় āĻŦা āĻĒ্āϰāϧাāύ āĻļাāĻ–া āĻāĻ•āϟি āϞাāϞ āĻ…āĻž্āϚāϞেāϰ āĻ…āĻ­্āϝāύ্āϤāϰে āĻ…āĻŦāϏ্āĻĨিāϤ āĻĨাāĻ•ে āϤāĻŦে āĻāϟি āĻŦিāĻ•াāϞ ā§Ē āϟা āĻĒāϰ্āϝāύ্āϤ āωāύ্āĻŽুāĻ•্āϤ āĻĨাāĻ•āĻŦে āϝাāϤে āĻļাāĻ–াāĻ—ুāϞি āϤাāĻĻেāϰ āύিāϝ়āĻŽিāϤ āϞেāύāĻĻেāύ āύিāϰāĻŦāϚ্āĻ›িāύ্āύāĻ­াāĻŦে āϏāĻŽ্āĻĒāύ্āύ āĻ•āϰāϤে āĻĒাāϰে।

āĻĸাāĻ•াāϰ āĻŽāϤিāĻিāϞ āĻ“ āĻĻিāϞāĻ•ুāĻļা āĻ…āĻž্āϚāϞ āĻāĻŦং āϚাāϟāĻ—্āϰাāĻŽেāϰ āφāĻ—্āϰাāĻŦাāĻĻ āĻ“ āĻ–াāϤুāύāĻ—āĻž্āϜ āĻ…āĻž্āϚāϞāĻ—ুāϞিāĻ•ে āϞাāϞ āĻ…āĻž্āϚāϞ āĻšিāϏাāĻŦে āϚিāĻš্āύিāϤ āĻ•āϰা āĻšāϞে, āĻ“āχāϏāĻŦ āĻ…āĻž্āϚāϞে āĻļাāĻ–াāĻ—ুāϞি āϏāĻ•াāϞ āĻĻāĻļāϟা āĻĨেāĻ•ে āĻĻুāĻĒুāϰ ⧍ āϟা āĻĒāϰ্āϝāύ্āϤ āϞেāύāĻĻেāύেāϰ āϜāύ্āϝ āωāύ্āĻŽুāĻ•্āϤ āĻĨাāĻ•āĻŦে। āĻ…āĻĢিāϏ āĻĻুāĻĒুāϰ āϤিāύāϟা āĻĒāϰ্āϝāύ্āϤ āĻ–োāϞা āĻĨাāĻ•āĻŦে।

āϤāĻŦে āĻ•েāύ্āĻĻ্āϰীāϝ় āĻŦ্āϝাংāĻ•েāϰ āύিāϰ্āĻĻেāĻļāύা āĻ…āύুāϝাāϝ়ী āĻšāϞুāĻĻ āĻ“ āϏāĻŦুāϜ āĻ…āĻž্āϚāϞে āĻŦ্āϝাংāĻ• āĻļাāĻ–াāĻ—ুāϞি āϞেāύāĻĻেāύেāϰ āϜāύ্āϝ āϏāĻ•াāϞ āĻĻāĻļāϟা āĻĨেāĻ•ে āĻĻুāĻĒুāϰ ⧍ āϟা āĻĒāϰ্āϝāύ্āϤ āĻ–োāϞা āĻĨাāĻ•āĻŦে, āĻ…āĻĢিāϏāĻ—ুāϞি āĻŦিāĻ•েāϞ āϚাāϰāϟা āĻĒāϰ্āϝāύ্āϤ āĻ–োāϞা āĻĨাāĻ•āĻŦে।
āϐāϤāĻŋāĻšāĻžāϏāĻŋāĻ• āϰ⧇āĻŽāĻŋāĻŸā§āϝāĻžāĻ¨ā§āϏ āĻ•āĻŽā§‡ āϜāĻžāĻŦāĻžāϰ āĻ­āϝāĻŧ

āϐāϤিāĻšাāϏিāĻ• āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻ•āĻŽে āϜাāĻŦাāϰ āĻ­āϝ়

āϐāϤিāĻšাāϏিāĻ• āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻ•āĻŽে āϜাāĻŦাāϰ āĻ­āϝ়


       āĻŽāĻ™্āĻ—āϞāĻŦাāϰ āφāύ্āϤāϰ্āϜাāϤিāĻ• āĻĒāϰিāĻŦাāϰ āϰেāĻŽিāϟেāύ্āϏ āĻĻিāĻŦāϏ

āφāχāĻāĻĢāĻāĻĄি āĻ•োāĻ­িāĻĄ -⧧⧝ āĻļāĻ• āĻ•āϰাāϰ āϜāύ্āϝ āĻĒāĻĻāĻ•্āώেāĻĒ āύেāĻ“āϝ়াāϰ āφāĻš্āĻŦাāύ āϜাāύিāϝ়েāĻ›ে

āĻļীāϰ্āώ āĻĻāĻļ āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻ—্āϰāĻšীāϤা āĻĻেāĻļāĻ—ুāϞিāϰ āĻŽāϧ্āϝে āĻŦাংāϞাāĻĻেāĻļ

āĻāχ āĻŦāĻ›āϰ āĻŦিāĻļ্āĻŦāĻŦ্āϝাāĻĒী āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒ্āϰāĻŦাāĻš āĻš্āϰাāϏেāϰ āϐāϤিāĻšাāϏিāĻ• āύিāĻŽ্āύে āύেāĻŽে āϝাāĻ“āϝ়াāϰ āφāĻļāĻ™্āĻ•াāϝ়, āϜাāϤিāϏংāϘেāϰ āφāύ্āϤāϰ্āϜাāϤিāĻ• āωāύ্āύāϝ়āύ āϤāĻšāĻŦিāϞ (āφāχāĻāĻĢāĻāĻĄি) āĻĻেāĻļāĻ—ুāϞিāĻ•ে āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻŦাāϜাāϰে āĻĒ্āϰāϤিāϝোāĻ—িāϤা, āύিāϝ়āύ্āϤ্āϰāĻŖ āĻāĻŦং āωāĻĻ্āĻ­াāĻŦāύāĻ•ে āϏāĻ•্āώāĻŽ āĻ•āϰাāϰ āϜāύ্āϝ āφāϰāĻ“ āωāĻĒāϝুāĻ•্āϤ āύীāϤি āĻāĻŦং āύিāϝ়āύ্āϤ্āϰāĻŖāĻŽূāϞāĻ• āĻĒāϰিāĻŦেāĻļ āĻŦিāĻ•াāĻļেāϰ āϜāύ্āϝ āφāĻš্āĻŦাāύ āϜাāύিāϝ়েāĻ›ে, āĻāĻŦং āĻāχ āĻĒāϰিāώেāĻŦাāĻ—ুāϞি āĻ…āĻĒāϰিāĻšাāϰ্āϝāĻ­াāĻŦে āϘোāώāĻŖা āĻ•āϰুāύ।

“āĻāχ āĻ•āĻ­িāĻĄ -⧧⧝ āĻŦিāϧিāύিāώেāϧāϟি āĻ…āĻ­িāĻŦাāϏী āĻ•āϰ্āĻŽীāĻĻেāϰ āύিāϝ়োāĻ—েāϰ āĻŽāϤো āĻ…āϰ্āĻĨāύৈāϤিāĻ• āĻ•্āώেāϤ্āϰāĻ—ুāϞিāϤে āĻ•্āώāϤিāĻ—্āϰāϏ্āĻĨ āĻ•āϰেāĻ›ে, āϝেāĻŽāύ āĻĒāϰ্āϝāϟāύ, āφāϤিāĻĨেāϝ়āϤা āĻāĻŦং āĻ•ৃāώিāĻ•াāϜ, āĻ•āĻ িāύ। āĻĢāϞāϏ্āĻŦāϰূāĻĒ, āĻ…āύেāĻ• āĻ…āĻ­িāĻŦাāϏী āĻŦেāĻ•াāϰ āĻŦা āĻŦেāĻ•াāϰ āĻšāϝ়ে āĻĒāĻĄ়েāĻ›েāύ। āφāχāĻāĻŽāĻāĻĄিāĻĄি āĻŽāĻ™্āĻ—āϞāĻŦাāϰ āϜাāύিāϝ়েāĻ›ে, āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒ্āϰāĻŦাāĻš āχāϤিāĻšাāϏেāϰ āϤীāĻŦ্āϰ āĻš্āϰাāϏ āĻĒাāĻŦে āĻŦāϞে āϧাāϰāĻŖা āĻ•āϰা āĻšāϚ্āĻ›ে, ⧍ā§Ļ⧍ā§Ļ āϏাāϞে āĻāϟি ⧍ā§Ļ āĻļāϤাংāĻļ āĻ•āĻŽেāĻ›ে।

āĻ—āϤ āĻŦāĻ›āϰ, āĻŦিāĻļ্āĻŦāĻŦ্āϝাāĻĒী āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒ্āϰāĻŦাāĻš āĻ…āύুāĻŽাāύ āĻ•āϰা āĻšāϝ়েāĻ›িāϞ 2018 550 āĻŦিāϞিāϝ়āύ āĻĄāϞাāϰেāϰāĻ“ āĻŦেāĻļি, āϝা 2018 āĻāϰ āĻāĻ•āχ āϏংāĻ–্āϝাāϰ āϤুāϞāύাāϝ় āĻĒ্āϰাāϝ় 5% āĻŦেāĻļি, āĻŦাংāϞাāĻĻেāĻļ āύিāϜেāχ āĻļীāϰ্āώ 10 āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒ্āϰাāĻĒāĻ• āĻĻেāĻļāĻ—ুāϞিāϰ āĻŽāϧ্āϝে āĻ…āĻŦāϏ্āĻĨাāύ āĻ•āϰāĻ›ে।

āϤāĻŦে, āϜাāϤিāϏংāϘেāϰ āĻāĻ• āĻĒ্āϰāϤিāĻŦেāĻĻāύে āĻŦāϞা āĻšāϝ়েāĻ›ে, ⧍ā§Ļ⧍ā§Ļ āϏাāϞে āωāύ্āύāϝ়āύāĻļীāϞ āĻĻেāĻļāĻ—ুāϞিāϤে āĻŦৈāĻļ্āĻŦিāĻ• āϰেāĻŽিāϟ্āϝাāύ্āϏ ā§§ā§§ā§Ļ āĻŦিāϞিāϝ়āύ āĻĄāϞাāϰ āĻš্āϰাāϏ āĻĒাāĻŦে āĻāĻŦং āĻāϰāĻĒāϰে āĻŦāĻšু āĻŦāĻ›āϰ āϧāϰে āĻĒ্āϰাāĻ•-āĻŽāĻšাāĻŽাāϰী āĻĒāϰ্āϝাāϝ়ে āĻĢিāϰে āφāϏāĻŦে āύা āĻŦāϞে āϧাāϰāĻŖা āĻ•āϰা āĻšāϚ্āĻ›ে।

āĻāχ āĻŦāĻ›āϰেāϰ āĻāĻĒ্āϰিāϞে āĻŦিāĻļ্āĻŦ āĻŦ্āϝাংāĻ• āĻ•োāĻ­িāĻĄ -⧧⧝ āĻāϰ āĻ•াāϰāĻŖে āĻāχ āĻŦāĻ›āϰ āĻŦাংāϞাāĻĻেāĻļেāϰ āϰেāĻŽিāϟ্āϝাāύ্āϏে 22% āĻš্āϰাāϏেāϰ āĻĒূāϰ্āĻŦাāĻ­াāϏ āĻĻিāϝ়েāĻ›ে।

āĻ…āĻ­িāĻŦাāϏী āĻ•āϰ্āĻŽীāϰা āĻŦāϰ্āϤāĻŽাāύে āϝে āϜাāϝ়āĻ—াāĻ—ুāϞিāϤে āϤাāϰা āĻŦাāϏ āĻ•āϰেāύ āĻāĻŦং āϤাāĻĻেāϰ āϏāĻŽ্āĻĒ্āϰāĻĻাāϝ়āĻ—ুāϞিāϤে āϏ্āĻŦāĻĻেāĻļে āĻĢিāϰে āφāϏেāύ āωāĻ­āϝ়েāϰ āϜāύ্āϝ āĻĒ্āϰāϝ়োāϜāύীāϝ় āĻ…āĻŦāĻĻাāύāĻ•াāϰী, āĻŦিāĻļ্āĻŦāĻŦ্āϝাāĻĒী āĻĒ্āϰাāϝ় 40 āϟি āĻĒ্āϰেāϰāĻŖ āĻāĻŦং 125 āϟিāϰāĻ“ āĻŦেāĻļি āĻ—্āϰāĻšāĻŖāĻ•াāϰী āĻĻেāĻļāĻ—ুāϞিāϤে āĻāϰ āĻĒ্āϰāĻ­াāĻŦ āĻĒāĻĄ়ে।

āφāύ্āϤāϰ্āϜাāϤিāĻ• āϰেāĻŽিāϟেāύ্āϏেāϰ āφāύ্āϤāϰ্āϜাāϤিāĻ• āĻĻিāĻŦāϏ (āφāχāĻĄিāĻāĻĢāφāϰ) āωāĻĒāϞāĻ•্āώে āϜাāϰি āĻ•āϰা āĻāĻ• āĻŦিāĻŦৃāϤিāϤে āφāχāĻāĻĢāĻāĻĄেāϰ āϰাāώ্āϟ্āϰāĻĒāϤি āĻ—িāϞāĻŦাāϰ্āϟ āĻāĻĢ āĻšুংāĻŦো āĻŦāϞেāĻ›েāύ: “āϏ্āĻŦāϞ্āĻĒ āĻ“ āĻŽāϧ্āϝ-āφāϝ়েāϰ āĻĻেāĻļে āĻĻāϰিāĻĻ্āϰ āĻĒāϰিāĻŦাāϰেāϰ āϜāύ্āϝ āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻāĻ•āϟি āϞাāχāĻĢāϞাāχāύ। COVID-19 āĻŽāĻšাāĻŽাāϰীāϰ āĻŽāϤো āϏāĻ™্āĻ•āϟেāϰ āϏāĻŽāϝ় āϤāĻšāĻŦিāϞেāϰ āĻĒ্āϰāĻŦাāĻšāĻ•ে āϏāĻšāϜ āĻ•āϰাāϰ āϜāύ্āϝ āϏāϰāĻ•াāϰāĻ—ুāϞিāϰ āĻŦ্āϝāĻŦāϏ্āĻĨা āύেāĻ“āϝ়া āωāϚিāϤ āĻāĻŦং āϝāĻĨাāϏাāϧ্āϝ āϚেāώ্āϟা āĻ•āϰা āωāϚিāϤ। "

āĻāχ āĻŦāĻ›āϰ, āϞāĻ•্āώ āϞāĻ•্āώ āĻ…āĻ­িāĻŦাāϏী āĻ•āϰ্āĻŽী āϚাāĻ•āϰি āĻšাāϰাāϤে āĻāĻŦং āĻ…āύেāĻ• āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒāϰিāĻŦাāϰāĻ•ে āĻšāĻ াā§Ž āĻĻাāϰিāĻĻ্āϰ্āϝāϏীāĻŽাāϰ āύিāϚে āĻ েāϞে āĻĻিāϝ়ে āĻ…āĻ­ূāϤāĻĒূāϰ্āĻŦ āĻĒāϰিāϏ্āĻĨিāϤিāϤে āφāχāĻĄিāĻāĻĢāφāϰ āĻĒাāϞāύ āĻ•āϰা āĻšāϚ্āĻ›ে।

āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒāϰিāĻŦাāϰāĻ—ুāϞি āωāĻ­āϝ়āχ āĻ•āĻ িāύ āĻĒāϰিāϏ্āĻĨিāϤিāϤে āĻĒāĻĄ়াāϰ āĻĒāϰেāĻ“ āϏāĻŽ্āĻĒāĻĻāĻļাāϞী āĻāĻŦং āϏ্āĻĨিāϤিāϏ্āĻĨাāĻĒāĻ•, āϤāĻŦে āĻ•োāĻ­িāĻĄ -⧧⧝ āĻĒুāϰো āĻŦ্āϝāĻŦāϏ্āĻĨাāĻ•ে āĻŦ্āϝাāĻšāϤ āĻ•āϰāĻ›ে āϝা āϏāϰাāϏāϰি āϜāĻĄ়িāϤ 200 āĻŽিāϞিāϝ়āύ āĻ…āĻ­িāĻŦাāϏী āĻ•āϰ্āĻŽী - āϤাāĻĻেāϰ āĻ…āϰ্āϧেāĻ• āύাāϰী - āϏাāϰা āĻŦিāĻļ্āĻŦ āϜুāĻĄ়ে āĻāĻŦং āϤাāĻĻেāϰ 800 āĻŽিāϞিāϝ়āύ āĻĒāϰিāĻŦাāϰেāϰ āϏāĻĻāϏ্āϝāϰা āĻĻেāĻļে āĻĢিāϰেāĻ›েāύ।

āϰোāĻŽ-āĻ­িāϤ্āϤিāĻ• āϜাāϤিāϏংāϘেāϰ āĻŦিāĻļেāώাāϝ়িāϤ āϏংāϏ্āĻĨা āφāχāĻāĻĢāĻāĻĄি āĻŦāϞেāĻ›ে: "āϞāĻ•āĻĄাāωāύেāϰ āϏāĻŽāϝ় āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒāϰিāώেāĻŦা āϏāϰāĻŦāϰাāĻšāĻ•াāϰীāĻĻেāϰ āĻŦāύ্āϧ āĻšāĻ“āϝ়া āĻ…āĻ­িāĻŦাāϏীāĻĻেāϰ āϤাāĻĻেāϰ āĻĒāϰিāĻŦাāϰāĻ—ুāϞিāϤে āĻ…āϰ্āĻĨ āĻĢেāϰāϤ āĻĒাāĻ াāύোāϰ āĻ•্āώāĻŽāϤা āφāϰāĻ“ āĻŦাāĻĄ়িāϝ়ে āϤুāϞেāĻ›ে।"

āĻĢ্āϰাāύ্āϏেāϰ āϏেāύেāĻ—াāϞি āĻĄাāϝ়াāϏ্āĻĒোāϰাāϰ āĻ—āϤ āĻŽাāϏে āĻāĻ•āϟি āφāχāĻāĻĢāĻāĻĄি āϏāĻŽীāĻ•্āώাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে āϝে āϝাāϰা āĻŦাāĻĄ়িāϤে āĻ…āϰ্āĻĨ āĻĒাāĻ াāύো āĻŦāύ্āϧ āĻ•āϰেāĻ›েāύ āĻŦা āĻš্āϰাāϏ āĻ•āϰেāĻ›েāύ āϤাāĻĻেāϰ āĻŽāϧ্āϝে āĻĒ্āϰাāϝ় ā§Šā§Ļ% āϤাāϰা āϤাāĻĻেāϰ āĻ…āϰ্āĻĨ āϏ্āĻĨাāύাāύ্āϤāϰāĻ•াāϰী āĻ…āĻĒাāϰেāϟāϰ āĻŦāύ্āϧ āĻĨাāĻ•াāϰ āĻ•াāϰāĻŖে āĻŦা āĻ…āύাāύুāώ্āĻ াāύিāĻ• āύেāϟāĻ“āϝ়াāϰ্āĻ•āĻ—ুāϞি āφāϰ āĻ•াāϜ āĻ•āϰে āύা āĻŦāϞেāχ āĻāϟি āĻ•āϰেāĻ›িāϞেāύ।

“āφāχāĻāĻĢāĻāĻĄি āĻāĻ–āύ āωāύ্āύāϝ়āύāĻļীāϞ āĻĻেāĻļāĻ—ুāϞিāϤে āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻš্āϰাāϏেāϰ āĻĒ্āϰāĻ­াāĻŦেāϰ āϏāύ্āϧাāύ āĻ•āϰāĻ›ে, āϝেāĻ–াāύে āĻŽাāϏে āĻĒ্āϰāϤি āĻŽাāϏে ⧍ā§Ļā§Ļ āĻĨেāĻ•ে $ā§Ļā§Ļ āĻŽাāϰ্āĻ•িāύ āĻĄāϞাāϰেāϰ āϰেāĻŽিāϟেāύ্āϏ āĻ—ৃāĻšāϏ্āĻĨাāϞিāϰ āφāϝ়েāϰ āĻĒ্āϰাāϝ় %ā§Ļ% āĻšāϝ়ে āĻĨাāĻ•ে,” āĻŦāϞেāĻ›েāύ āφāχāĻāĻĢāĻāĻĄেāϰ āĻĢিāύাāύ্āϏিংāϝ়েāϰ āĻĒ্āϰāϧাāύ āĻĒেāĻĄ্āϰো āĻĄি āĻ­্āϝাāϏāĻ•āύāϏ্āϞোāϏ āϰেāĻŽিāϟ্āϝাāύ্āϏেāϰ āϜāύ্āϝ āϏুāĻŦিāϧা।

āĻĒেāĻĄ্āϰো āĻĄি āĻ­্āϝাāϏāĻ•āύāϏ্āϞোāϏ āϝোāĻ— āĻ•āϰেāĻ›েāύ, "āϝāĻĻিāĻ“ āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻš্āϰাāϏ āĻĻেāĻļ āĻāĻŦং āϏāĻŽ্āĻĒ্āϰāĻĻাāϝ়েāϰ āĻŽāϧ্āϝে āϏāĻŽাāύāĻ­াāĻŦে āĻš্āϰাāϏ āĻĒাāĻŦে āύা, āϤāĻŦে āĻāϰ āĻĒ্āϰāĻ­াāĻŦ āϏāĻŽ্āĻ­āĻŦāϤ āĻĒāϞ্āϞী āĻ…āĻž্āϚāϞে āϝেāĻ–াāύে āωāϞ্āϞেāĻ–āϝোāĻ—্āϝ āĻĒāϰিāĻŽাāĻŖে āϰেāĻŽিāϟ্āϝাāύ্āϏ āϏāĻŦāϚেāϝ়ে āĻŦেāĻļি āĻ—āĻŖāύা āĻ•āϰা āϝাāϝ় āϤা āϝāĻĨেāώ্āϟ āĻšāĻŦে।"

āĻ•āϝ়েāĻ• āĻšাāϜাāϰ āĻ…āĻ­িāĻŦাāϏী āϤাāĻĻেāϰ āĻ—্āϰাāĻŽীāĻŖ āϏāĻŽ্āĻĒ্āϰāĻĻাāϝ়āĻ—ুāϞিāϤে āĻĢিāϰে āĻāϏেāĻ›েāύ। āĻāĻ•āχ āϏāĻŽāϝ়ে, āϤাāĻĻেāϰ āĻĒāϰিāĻŦাāϰāĻ—ুāϞি āϞāĻ•āĻĄাāωāύ āĻŦ্āϝāĻŦāϏ্āĻĨা āĻĻ্āĻŦাāϰা āύেāϤিāĻŦাāϚāĻ•āĻ­াāĻŦে āĻĒ্āϰāĻ­াāĻŦিāϤ āĻšāϝ়েāĻ›ে āϝা āϤাāĻĻেāϰ āĻŽূāϞ āĻĻেāĻļāĻ—ুāϞিāϤে āĻ…āϰ্āĻĨāύৈāϤিāĻ• āĻ•াāϰ্āϝāĻ•āϞাāĻĒāĻ•ে āĻ…āĻŦāĻļ āĻ•āϰে āĻĻিāϝ়েāĻ›ে āĻāĻŦং āϜীāĻŦāύ-āϜীāĻŦিāĻ•া āϧ্āĻŦংāϏ āĻ•āϰেāĻ›ে destroyed

āωāĻ­āϝ় āĻĒāĻ•্āώেāϰ āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻ•āϰিāĻĄোāϰ āĻāĻ•āχ āϏাāĻĨে āĻĒ্āϰāĻ­াāĻŦিāϤ āĻšāĻ“āϝ়াāϰ āϏাāĻĨে āϏাāĻĨে, āĻŦাāϧাāĻ—ুāϞি āϏāϰাāϏāϰি āĻāĻ• āĻŦিāϞিāϝ়āύ āĻŽাāύুāώেāϰ āϜীāĻŦāύ āĻ“ āϜীāĻŦিāĻ•াāϤে āĻĒ্āϰāĻ­াāĻŦিāϤ āĻ•āϰে: 200 āĻŽিāϞিāϝ়āύ āĻ…āĻ­িāĻŦাāϏী āϝাāϰা āϤাāĻĻেāϰ 800 āĻŽিāϞিāϝ়āύ āφāϤ্āĻŽীāϝ়āĻ•ে āĻ…āϰ্āĻĨ āĻĒাāĻ াāϝ়।

āĻāϰ āĻŽāϧ্āϝে āĻĒ্āϰাāϝ় āĻ…āϰ্āϧেāĻ• āĻĒāϰিāĻŦাāϰ āĻ—্āϰাāĻŽীāĻŖ āĻ…āĻž্āϚāϞে āĻŦাāϏ āĻ•āϰে āϝেāĻ–াāύে āĻĻাāϰিāĻĻ্āϰ্āϝ āĻāĻŦং āĻ•্āώুāϧা āϏāĻŦāϚেāϝ়ে āĻŦেāĻļি।

āĻ āĻŦāĻ›āϰ, āϞāĻ•্āώ āϞāĻ•্āώ āĻĒāϰিāĻŦাāϰ āϝাāϰা āϤাāĻĻেāϰ āϰেāĻŽিāϟ্āϝাāύ্āϏেāϰ āωāĻĒāϰ āύিāϰ্āĻ­āϰ āĻ•āϰে āϤাāϰা āĻĻাāϰিāĻĻ্āϰ্āϝāϏীāĻŽাāϰ āύীāϚে āύেāĻŽে āφāϏāĻŦে, āĻĢāϞāϏ্āĻŦāϰূāĻĒ āφāϰāĻ“ āĻ•্āώুāϧাāϰ্āϤ āĻšāĻŦে āĻāĻŦং āĻļিāĻ•্āώা āĻ“ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āĻ•āĻŽ āĻŦ্āϝāϝ় āĻšāĻŦে, āφāχāĻāĻĢāĻāĻĄি āωāĻĻ্āĻŦেāĻ— āĻĒ্āϰāĻ•াāĻļ āĻ•āϰেāĻ›ে।

“āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒāϰিāώেāĻŦা āϏংāĻ•āϟেāϰ āĻŽāϧ্āϝ āĻĻিāϝ়ে āϚāϞাāϰ āĻĢāϞে āĻ…āĻŦāĻļ্āϝāχ āĻ…āĻ­িāĻŦাāϏীāĻĻেāϰ āφāϝ়েāϰ āĻš্āϰাāϏেāϰ āĻĒ্āϰāĻ­াāĻŦ āĻ•িāĻ›ুāϟা āĻš্āϰাāϏ āĻĒাāĻŦে, āϤাāϤ্āĻ•্āώāĻŖিāĻ•āĻ­াāĻŦে āĻŦ্āϝāĻŦāϏ্āĻĨাāϟিāϰ āφāϰāĻ“ āĻŦৃāĻšāϤ্āϤāϰ āϏংāϏ্āĻ•াāϰ āĻ•āϰা āĻĻāϰāĻ•াāϰ āϝাāϤে āĻāχ āϏংāĻ•āϟ āĻļেāώ āĻšāĻ“āϝ়াāϰ āĻĒāϰে, āĻ…āĻ­িāĻŦাāϏীāϰা āϤাāĻĻেāϰ āĻ…āϰ্āĻĨ āĻĻ্āϰুāϤ, āύিāϰাāĻĒāĻĻে āĻĻেāĻļে āĻĒ্āϰেāϰāĻŖ āĻ•āϰāϤে āĻĒাāϰে āĻāĻŦং āϏāϏ্āϤা, "āĻĄি āĻ­াāϏāĻ•āύāϏ্āϞোāϏ āĻŦāϞেāĻ›িāϞেāύ।

āĻĒāϰিāϏ্āĻĨিāϤি āĻŽোāĻ•াāĻŦেāϞাāϝ় āφāχāĻāĻĢāĻāĻĄি āϏāϰāĻ•াāϰāĻ—ুāϞিāĻ•ে āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻŦাāϜাāϰে āĻĒ্āϰāϤিāϝোāĻ—িāϤা, āύিāϝ়āύ্āϤ্āϰāĻŖ āĻ“ āωāĻĻ্āĻ­াāĻŦāύ āϏāĻ•্āώāĻŽ āĻ•āϰাāϰ āϜāύ্āϝ āφāϰāĻ“ āĻ…āύুāĻ•ূāϞ, āύীāϤিāĻŽাāϞা āĻāĻŦং āύিāϝ়āύ্āϤ্āϰāĻŖāĻ•াāϰী āĻĒāϰিāĻŦেāĻļ āĻŦিāĻ•াāĻļেāϰ āφāĻš্āĻŦাāύ āϜাāύিāϝ়েāĻ›ে āĻāĻŦং āĻāχ āĻĒāϰিāώেāĻŦাāĻ—ুāϞি āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻŦāϞে āϘোāώāĻŖা āĻ•āϰেāĻ›ে।

āχāωāĻāύ āĻāϜেāύ্āϏি āφāϰāĻ“ āĻŦāϞেāĻ›ে, āĻŦ্āϝāϝ় āĻš্āϰাāϏ āĻ•āϰāϤে, āĻ—āϤি āωāύ্āύāϤ āĻ•āϰāϤে, āϏুāϰāĻ•্āώা āĻŦাāĻĄ়াāϤে āĻāĻŦং āĻĒ্āϰāϤ্āϝāύ্āϤ āĻ…āĻž্āϚāϞে āĻĄিāϜিāϟাāϞ āĻŽাāϧ্āϝāĻŽে āĻĒ্āϰāĻŦাāĻš āĻŦৃāĻĻ্āϧিāϰ āϜāύ্āϝ āĻŦেāϏāϰāĻ•াāϰী āĻ–াāϤ āϏংāϏ্āĻĨাāĻ—ুāϞিāĻ•ে āϰেāĻŽিāϟ্āϝাāύ্āϏ āϟ্āϰাāύ্āϏāĻĢাāϰেāϰ āϜāύ্āϝ āωāĻĻ্āĻ­াāĻŦāύী āĻĒ্āϰāϝুāĻ•্āϤিāĻ—āϤ āϏāĻŽাāϧাāύ āĻŦিāĻ•াāĻļে āĻŦিāύিāϝ়োāĻ— āĻ•āϰা āωāϚিāϤ।

āĻāϤে āφāϰāĻ“ āĻŦāϞা āĻšāϝ়েāĻ›ে, āĻŦিāĻļেāώāϤ āĻĻāϰিāĻĻ্āϰ āĻ—্āϰাāĻŽাāĻž্āϚāϞে āϰেāĻŽিāϟ্āϝাāύ্āϏ āϏেāĻŦাāϰ āĻĒ্āϰāĻŦেāĻļাāϧিāĻ•াāϰ āωāύ্āύāϤ āĻ•āϰা āĻĻāϰāĻ•াāϰ।

āĻĄিāϜিāϟাāϞ āĻĒāĻŖ্āϝāĻ—ুāϞিāϰ āĻŦিāĻ•াāĻļ āĻ“ āĻŦ্āϝāĻŦāĻšাāϰেāϰ āϜāύ্āϝ āωāϤ্āϏাāĻš āĻĻেāĻ“āϝ়া āωāϚিāϤ āϝা āϰেāĻŽিāϟেāύ্āϏāĻ—ুāϞিāĻ•ে āϏāĻŽ্āĻĒূāϰ্āĻŖ āφāϰ্āĻĨিāĻ• āĻĒāϰিāώেāĻŦাāϰ āϏাāĻĨে āϏংāϝুāĻ•্āϤ āĻ•āϰে, āϝাāϤে āĻ…āĻ­িāĻŦাāϏী āĻāĻŦং āϤাāĻĻেāϰ āĻĒāϰিāĻŦাāϰ āϤাāĻĻেāϰ āĻāĻŦং āϤাāĻĻেāϰ āϏāĻŽ্āĻĒ্āϰāĻĻাāϝ়েāϰ āϜāύ্āϝ āφāϰāĻ“ āĻŦেāĻļি āϏুāϝোāĻ— āϤৈāϰি āĻ•āϰাāϰ āϜāύ্āϝ āϤাāĻĻেāϰ āĻ…āϰ্āĻĨ āϏāĻž্āϚāϝ় āĻāĻŦং āĻŦিāύিāϝ়োāĻ—ে āωāϤ্āϏাāĻšিāϤ āĻ•āϰāϤে āĻĒাāϰে।

āĻŽাāϰ্āϚ āĻĨেāĻ•ে, āφāχāĻāĻĢāĻāĻĄি āĻāĻ•āϟি āĻŦিāĻļ্āĻŦāĻŦ্āϝাāĻĒী "āϰেāĻŽিāϟেāύ্āϏāϏ āĻ•āĻŽিāωāύিāϟি āϟাāϏ্āĻ• āĻĢোāϰ্āϏ" āύেāϤৃāϤ্āĻŦ āĻĻিāϝ়েāĻ›ে, āϝাāϰ āĻŽāϧ্āϝে āϰāϝ়েāĻ›ে 35 āϟি āφāύ্āϤāϰ্āϜাāϤিāĻ• āϏংāϏ্āĻĨা, āφāύ্āϤঃāϏāϰāĻ•াāϰী āϏংāϏ্āĻĨা, āĻļিāϞ্āĻĒ āĻ“ āĻŦেāϏāϰāĻ•াāϰী āĻ–াāϤেāϰ āĻ—্āϰুāĻĒ āĻāĻŦং āĻĄাāϝ়াāϏ্āĻĒোāϰা āϏংāϏ্āĻĨাāϰ āύেāϟāĻ“āϝ়াāϰ্āĻ•āĻ—ুāϞি āϏāĻŽāύ্āĻŦিāϤ। āϟাāϏ্āĻ•āĻĢোāϰ্āϏ āϰেāĻŽিāϟ্āϝাāύ্āϏ āĻĒ্āϰেāϰāĻŖ āĻ“ āĻĒ্āϰাāĻĒ্āϤিāϤে āĻĒ্āϰāϤ্āϝāĻ•্āώāĻ­াāĻŦে āϜāĻĄ়িāϤ āĻāĻ• āĻŦিāϞিāϝ়āύ āĻŽাāύুāώেāϰ āϜীāĻŦāύে āĻ•োāĻ­িāĻĄ -⧧⧝ āϏংāĻ•āϟেāϰ āĻĒ্āϰāĻ­াāĻŦ āĻš্āϰাāϏে āϏāĻšাāϝ়āϤাāϰ āϜāύ্āϝ āĻāĻ•াāϧিāĻ• āĻ•ংāĻ•্āϰিāϟ āĻŦ্āϝāĻŦāϏ্āĻĨা āύিāϝ়ে āĻ•াāϜ āĻ•āϰāĻ›ে।